AG
Artal Group Portfolio holdings
AUM
$930M
1-Year Return
3.57%
This Quarter Return
+7.88%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$3.12B
AUM Growth
+$1.44B
(+86%)
Cap. Flow
+$1.36B
Cap. Flow
% of AUM
43.59%
Top 10 Holdings %
Top 10 Hldgs %
70.07%
Holding
139
New
20
Increased
22
Reduced
20
Closed
25
Top Buys
| 1 |
CAVA Group
CAVA
|
$1.31B |
| 2 |
Lexicon Pharmaceuticals
LXRX
|
$63.6M |
| 3 |
SLRN
ACELYRIN
SLRN
|
$38.1M |
| 4 |
MoonLake Immunotherapeutics
MLTX
|
$20.4M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$18.7M |
Top Sells
| 1 |
WW
WW International
WW
|
$61.1M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$15.8M |
| 3 |
Apellis Pharmaceuticals
APLS
|
$15.1M |
| 4 |
Fate Therapeutics
FATE
|
$14.8M |
| 5 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$13.1M |
Sector Composition
| 1 | Healthcare | 56.49% |
| 2 | Consumer Discretionary | 42.78% |
| 3 | Technology | 0.24% |
| 4 | Financials | 0.2% |
| 5 | Real Estate | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLN
51
Silence Therapeutics
SLN
$247M
| $9.35M | 0.29% |
1,700,000
+1,194,926
| +237% | +$6.57M |
|
52
Dyne Therapeutics
DYN
$1.88B
| $9.17M | 0.28% |
815,085
+282,476
| +53% | +$3.18M |
|
53
Vor Biopharma
VOR
$244M
| $8.31M | 0.26% |
2,688,015
-104,790
| -4% | -$324K |
|
54
Ovid Therapeutics
OVID
$91.7M
| $8.2M | 0.25% |
2,500,000
| – | – |
|
|
FUSN
55
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $8.06M | 0.25% |
1,725,000
-250,000
| -13% | -$1.17M |
|
56
Repare Therapeutics
RPTX
$72.6M
| $7.41M | 0.23% |
700,000
| – | – |
|
57
Day One Biopharmaceuticals
DAWN
$759M
| $5.97M | 0.19% |
+500,000
| New | +$5.97M |
|
|
ARAV
58
DELISTED
Aravive, Inc. Common Stock
ARAV
| $5.76M | 0.18% |
4,572,515
| – | – |
|
|
VERV
59
DELISTED
Verve Therapeutics
VERV
| $5.63M | 0.17% |
300,000
| – | – |
|
|
ITOS
60
DELISTED
iTeos Therapeutics
ITOS
| $5.3M | 0.16% |
400,000
| – | – |
|
61
KE Holdings
BEKE
$21.9B
| $5.2M | 0.16% |
350,000
+75,000
| +27% | +$1.11M |
|
|
NBTX
62
Nanobiotix
NBTX
$411M
| $5.07M | 0.16% |
1,000,000
| – | – |
|
|
HOOK
63
DELISTED
HOOKIPA Pharma
HOOK
| $4.99M | 0.15% |
566,641
+381,679
| +206% | +$3.36M |
|
64
Solid Biosciences
SLDB
$433M
| $4.76M | 0.15% |
909,219
| – | – |
|
|
SYRS
65
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $4.65M | 0.14% |
1,475,744
| – | – |
|
66
TSMC
TSM
$1.22T
| $4.29M | 0.13% |
42,500
+12,500
| +42% | +$1.26M |
|
|
PFTA
67
DELISTED
Perception Capital Corp. III Class A Ordinary Share
PFTA
| $3.94M | 0.12% |
380,000
| – | – |
|
68
ALX Oncology
ALXO
$57.8M
| $3.76M | 0.12% |
500,000
| – | – |
|
69
Gossamer Bio
GOSS
$571M
| $3.63M | 0.11% |
3,028,171
| – | – |
|
70
Lucid Motors
LCID
$4.97B
| $3.38M | 0.1% |
+49,000
| New | +$3.38M |
|
71
Avidity Biosciences
RNA
$6.24B
| $3.33M | 0.1% |
300,000
-211,962
| -41% | -$2.35M |
|
72
Kanzhun
BZ
$11.1B
| $3.31M | 0.1% |
+220,000
| New | +$3.31M |
|
73
Tourmaline Bio
TRML
$645M
| $2.78M | 0.09% |
91,426
| – | – |
|
74
Cullinan Oncology
CGEM
$408M
| $2.69M | 0.08% |
250,000
| – | – |
|
75
Stoke Therapeutics
STOK
$1.08B
| $2.66M | 0.08% |
250,000
| – | – |
|